Clinical Trials Browser

Salivary Gland Neoplasms × amivantamab × 90 days × Clear all

NCT05074940 2026-05-08

Amivantamab in Adenoid Cystic Carcinoma

Phase 2 Active not recruiting

21 enrolled 13 charts

Carcinoma, Adenoid Cystic, Salivary Gland Neoplasms